✦ LIBER ✦

Phase II Study of Nelarabine With Hyper-CVAD in Patients With Previously Untreated T cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (LL)

✍ Scribed by Jain, Preetesh; Kantarjian, Hagop; Thomas, Deborah; Ravandi, Farhad; Kadia, Tapan; Burger, Jan; Borthakur, Gautam; Cortes, Jorge; Daver, Naval; Jabbour, Elias; Koller, Charles; Konopleva, Marina; Pemmaraju, Naveen; Kelly, Mary A.; Garris, Rebecca; O'Brien, Susan; Faderl, Stefan

Book ID: 122199896
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 73 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.07.065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nelarabine induces complete remissions i

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801

✍ DeAngelo, D. J.; Yu, D.; Johnson, J. L.; Coutre, S. E.; Stone, R. M.; Stopeck, A 📂 Article 📅 2007 🏛 American Society of Hematology 🌐 English ⚖ 247 KB

Prospective phase II study of rituximab

Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma

✍ Oki, Yasuhiro; Westin, Jason R.; Vega, Francisco; Chuang, Hubert; Fowler, Nathan 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

A phase II study of sequential combinati

A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia

✍ Tefferi, A; Li, C-Y; Reeder, C B; Geyer, S M; Allmer, C; Levitt, R; Michalak, J 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

A phase I and pharmacodynamic study of s

A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia

✍ Brenda W Cooper; Erin Donaher; Hillard M Lazarus; Sylvan B Green; David M Gosky; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 863 KB

Randomized phase II study of weekly doce

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma

✍ Lee M. Krug; Vincent A. Miller; Jyoti Patel; John Crapanzano; Christopher G. Azz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

P-403 Vatalanib in patients with previou

P-403 Vatalanib in patients with previously untreated advanced malignant mesothelioma (MM): Preliminary analysis of a phase II study by the Cancer and Leukemia Group B (CALGB 30107)

✍ Jahan, T.; Gu, L.; Wang, X.; Kratzke, R.; Green, M.; Vokes, E.; Kindler, H. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB